Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Norbert Schmitz, Stephen Robinson et al.|Journal of Clinical Oncology|2007Cited by 320
Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J.W. van Kampen, Anna Sureda, Carmen Canals et al.|Journal of Clinical Oncology|2011Cited by 216
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Norbert Schmitz, Juan Besalduch et al.|Haematologica|2011Cited by 215
Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F. Duarte, Anna Sureda, Carmen Canals et al.|Journal of Clinical Oncology|2010Cited by 204
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen Robinson, Anna Sureda, Carmen Canals et al.|Haematologica|2008Cited by 169